Stopping HRT Does Not Accelerate Bone Loss

MAY 01, 2002

Women who stop taking hormone replacement therapy (HRT) may lose bone mineral density (BMD), but their rate of bone loss is similar to that among women who never took HRT, according to data from the Postmenopausal Estrogen/Progestin Intervention Study. As reported in the Archives of Internal Medicine, a total of 495 postmenopausal women were randomized to HRT or placebo and were followed for 7 years.

After treatment cessation, women who took HRT for 1 year had an annual rate of BMD loss of 0.5% at the hip and 0.81% at the spine.

Among women who took HRT for 3 years, this rate was 1.01% at the hip and 1.04% at the spine following treatment cessation. Women who did not take HRT lost about 1% of BMD in the first year of the study and about 0.5% annually thereafter.



SHARE THIS SHARE THIS
0

Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.